- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 18 Years - 100 Years
- Sexes
- All
Research at a glance
Top areas of exploration
- Mycobacterium tuberculosis , 21 publications
- Antitubercular Agents , 20 publications
- COVID-19 , 18 publications
- Tuberculosis, Pulmonary , 15 publications
Research activity
Active clinical trials
- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 18 Years - 100 Years
- Sexes
- All
- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 18 Years - 100 Years
- Sexes
- All
My publications
Filter publications
235 publications
2022
Health effects of radioactive contaminated dust in the aftermath of potential nuclear accident in Ukraine.
Frontiers in public health
PubMed • Publisher's site2022
Immunomodulatory agents for COVID-19 treatment: possible mechanism of action and immunopathology features
Molecular and Cellular Biochemistry
PubMed • Publisher's site2022
Pericardial Epithelioid Inflammatory Myofibroblastic Sarcoma: An Atypical Presentation.
Cureus
PubMed • Publisher's site2022
Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis: A Narrative Review.
Pulmonary therapy
PubMed • Publisher's site2022
SARS-CoV-2 cell entry beyond the ACE2 receptor
Molecular Biology Reports
PubMed • Publisher's site